Artivion (AORT) CEO sells 17,580 shares at $44.619 for taxes
Artivion (AORT) reported an insider transaction by President & CEO James P. Mackin.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Artivion (AORT) reported an insider transaction by President & CEO James P. Mackin.
On 11/10/2025, 17,580 shares of common stock were sold at $44.619 in a sell-to-cover tied to RSU vesting to satisfy tax withholding; the filing states this was not a discretionary trade.
After the transaction, he directly beneficially owned 835,203 shares.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock | 17,580 | $44.619 | $784K |
Footnotes (1)
- F1. These shares were sold upon the vesting of restricted stock units to pay tax withholding obligations. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did Artivion (AORT) disclose in this Form 4?
What price and date were involved in the AORT insider sale?
What is the role of the reporting person at Artivion (AORT)?
Was this an open-market discretionary sale?
AI-generated analysis. How Rhea-AI works. Not financial advice.